Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 246,960 | 78,438 | 84,260 | 75,916 | 109,997 |
| Marketable Securities | 345,981 | 350,391 | 401,521 | 473,764 | 499,586 |
| Receivables | N/A | N/A | 19,000 | N/A | N/A |
| TOTAL | $606,819 | $440,603 | $515,330 | $563,703 | $619,387 |
| Non-Current Assets | |||||
| PPE Net | 22,490 | 20,498 | 18,773 | 18,449 | 17,757 |
| Other Non-Current Assets | 58,826 | 61,371 | 57,452 | 32,891 | 32,199 |
| TOTAL | $81,316 | $81,869 | $76,225 | $51,340 | $49,956 |
| Total Assets | $688,135 | $522,472 | $591,555 | $615,043 | $669,343 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,215 | 8,609 | 5,954 | 8,397 | 11,482 |
| Accrued Expenses | 54,852 | 43,957 | 37,005 | 44,361 | 37,994 |
| TOTAL | $86,471 | $82,350 | $75,614 | $89,988 | $95,854 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 17,580 | 25,993 | 27,420 | 30,591 | 38,364 |
| Other Non-Current Liabilities | 52,906 | 52,695 | 46,696 | 19,984 | 20,289 |
| TOTAL | $62,917 | $67,870 | $68,338 | $44,138 | $46,496 |
| Total Liabilities | $149,388 | $150,220 | $143,952 | $134,126 | $142,350 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,843 | 76,883 | 76,449 | 76,236 | 75,887 |
| Common Shares | 102 | 77 | 76 | 76 | 76 |
| Retained earnings | -1,003,226 | -925,005 | -838,584 | -795,120 | -738,769 |
| Other shareholders' equity | 105 | 119 | -20 | 226 | 150 |
| TOTAL | $538,747 | $372,252 | $447,603 | $480,917 | $526,993 |
| Total Liabilities And Equity | $688,135 | $522,472 | $591,555 | $615,043 | $669,343 |